AF
BNGO icon

Aviso Financial’s Bionano Genomics BNGO Stock Holding History

Aviso Financial’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1 Hold
1
– – ﹤0.01% 337
2025
Q4 		$1 Hold
1
– – ﹤0.01% 345
2025
Q3 		$1 Hold
1
– – ﹤0.01% 345
2025
Q2 		$3 Hold
1
– – ﹤0.01% 349
2025
Q1 		$2 Sell
1
-1
-50% -$7 ﹤0.01% 350
2024
Q4 		$29 Hold
2
– – ﹤0.01% 356
2024
Q3 		$46 Hold
2
– – ﹤0.01% 356
2024
Q2 		$83 Buy
+2
New +$110 ﹤0.01% 345

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Aviso Financial's BNGO Position: Q1 2026 in Review

Aviso Financial held its Bionano Genomics (BNGO) position steady in Q1 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #337.

Aviso Financial first reported a position in BNGO in Q2 2024 and has held it in 8 quarters since. The position peaked at $83 in Q2 2024. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

  • Aviso Financial held 1 share of Bionano Genomics worth $1 as of Q1 2026.
  • Aviso Financial left its Bionano Genomics share count unchanged in Q1 2026.
  • Bionano Genomics made up ﹤0.01% of Aviso Financial's portfolio in Q1 2026, its #337 holding.
  • Aviso Financial first reported a position in Bionano Genomics in Q2 2024 and has held it in 8 quarters since.
  • Aviso Financial's Bionano Genomics position peaked at $83 in Q2 2024.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on Aviso Financial's 13F filing for Q1 2026, filed 14 May 2026.